Accenture Total Cost of Revenue increased by 0.3% to $12.58B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.7%, from $11.68B to $12.58B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 8.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.86B | $8.95B | $10.05B | $10.52B | $10.84B | $10.48B | $10.56B | $10.98B | $11.04B | $10.80B | $10.78B | $10.92B | $10.97B | $11.07B | $11.87B | $11.68B | $11.90B | $11.99B | $12.55B | $12.58B |
| QoQ Change | — | +1.1% | +12.2% | +4.7% | +3.1% | -3.4% | +0.8% | +4.0% | +0.5% | -2.1% | -0.3% | +1.3% | +0.4% | +0.9% | +7.2% | -1.5% | +1.9% | +0.7% | +4.7% | +0.3% |
| YoY Change | — | — | — | — | +22.4% | +17.0% | +5.1% | +4.3% | +1.8% | +3.1% | +2.0% | -0.5% | -0.6% | +2.5% | +10.1% | +7.0% | +8.5% | +8.3% | +5.7% | +7.7% |